Abstract:Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and its receptor, death receptor 4 (DR4), have been implicated in the development of endothelial dysfunction and atherosclerosis. However, the signaling mechanism mediating DR4 activation leading to endothelial injury remains unclear. We recently demonstrated that ceramide production via hydrolysis of membrane sphingomyelin by acid sphingomyelinase (ASM) results in membrane raft (MR) clustering and the formation of important redox signaling platforms, which play a crucial role in amplifying redox signaling in endothelial cells leading to endothelial dysfunction. The present study aims to investigate whether TRAIL triggers MR clustering via lysosome fusion and ASM activation, thereby conducting transmembrane redox signaling and changing endothelial function. Using confocal microscopy, we found that TRAIL induced MR clustering and co-localized with DR4 in coronary arterial endothelial cells (CAECs) isolated from wild-type (Smpd1 +/+) mice. Furthermore, TRAIL triggered ASM translocation, ceramide production, and NADPH oxidase aggregation in MR clusters in Smpd1 +/+ CAECs, whereas these observations were not found in Smpd1 −/− CAECs. Moreover, ASM deficiency reduced TRAIL-induced O2 −⋅ production in CAECs and abolished TRAIL-induced impairment on endothelium-dependent vasodilation in small resistance arteries. By measuring fluorescence resonance energy transfer, we found that Lamp-1 (lysosome membrane marker protein) and ganglioside GM1 (MR marker) were trafficking together in Smpd1 +/+ CAECs, which was absent in Smpd1 −/− CAECs. Consistently, fluorescence imaging of living cells with specific lysosome probes demonstrated that TRAIL-induced lysosome fusion with membrane was also absent in Smpd1 −/− CAECs. Taken together, these results suggest that ASM is essential for TRAIL-induced lysosomal trafficking, membrane fusion and formation of MR redox signaling platforms, which may play an important role in DR4-mediated redox signaling in CAECs and consequently endothelial dysfunction.

Membrane Raft Redox Signalosomes in Endothelial Cells

Ceramide in Redox Signaling and Cardiovascular Diseases

Lipid Raft-Redox Signaling Platforms in Plasma Membrane

Ceramide: a Novel Player in Reactive Oxygen Species-Induced Signaling?

Requirement of Translocated Lysosomal V1 H(+)-ATPase for Activation of Membrane Acid Sphingomyelinase and Raft Clustering in Coronary Endothelial Cells.

Ceramide-enriched membrane domains--structure and function.

Lipid Raft Clustering and Redox Signaling Platform Formation in Coronary Arterial Endothelial Cells

Forum Original Research Communication Contribution of Lysosomal Vesicles to the Formation of Lipid Raft Redox Signaling Platforms in Endothelial Cells

Contribution of lysosomal vesicles to the formation of lipid raft redox signaling platforms in endothelial cells.

Signaling Components of Redox Active Endosomes: the Redoxosomes

The Plasma Membrane: A Platform for Intra- and Intercellular Redox Signaling

Membrane Raft-Lysosome Redox Signalling Platforms in Coronary Endothelial Dysfunction Induced by Adipokine Visfatin.

Rafting on the Plasma Membrane: Lipid Rafts in Signaling and Disease

Redox Signaling in Endosomes Using the Example of EGF Receptors: A Graphical Review

TRAIL Death Receptor 4 Signaling Via Lysosome Fusion and Membrane Raft Clustering in Coronary Arterial Endothelial Cells: Evidence from ASM Knockout Mice

Membrane Raft Redox Signalling Contributes to Endothelial Dysfunction and Vascular Remodelling of Thoracic Aorta in Angiotensin II‐infused Rats

Rafting on the Evidence for Lipid Raft-like Domains as Hubs Triggering Environmental Toxicants' Cellular Effects

Lysosomal Targeting and Trafficking of Acid Sphingomyelinase to Lipid Raft Platforms in Coronary Endothelial Cells.

SNARE-mediated Rapid Lysosome Fusion in Membrane Raft Clustering and Dysfunction of Bovine Coronary Arterial Endothelium.

Sphingomyelin and Its Role in Cellular Signaling.

Membrane Rafts-Redox Signalling Pathway Contributes To Renal Fibrosis Via Modulation Of The Renal Tubular Epithelial-Mesenchymal Transition